- Home
- LXP vs AMRX Comparison
LXP vs AMRX Comparison
Compare LXP & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXP
- AMRX
- Stock Information
- Founded
- LXP 1993
- AMRX 2002
- Country
- LXP United States
- AMRX United States
- Employees
- LXP N/A
- AMRX N/A
- Industry
- LXP Real Estate Investment Trusts
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- LXP Real Estate
- AMRX Health Care
- Exchange
- LXP Nasdaq
- AMRX Nasdaq
- Market Cap
- LXP 2.5B
- AMRX 2.5B
- IPO Year
- LXP 1993
- AMRX N/A
- Fundamental
- Price
- LXP $8.36
- AMRX $7.78
- Analyst Decision
- LXP Buy
- AMRX Strong Buy
- Analyst Count
- LXP 3
- AMRX 5
- Target Price
- LXP $11.50
- AMRX $10.00
- AVG Volume (30 Days)
- LXP 2.1M
- AMRX 1.2M
- Earning Date
- LXP 02-13-2025
- AMRX 11-08-2024
- Dividend Yield
- LXP 6.25%
- AMRX N/A
- EPS Growth
- LXP N/A
- AMRX N/A
- EPS
- LXP 0.06
- AMRX N/A
- Revenue
- LXP $340,563,000.00
- AMRX $2,680,420,000.00
- Revenue This Year
- LXP N/A
- AMRX $17.86
- Revenue Next Year
- LXP $3.59
- AMRX $3.90
- P/E Ratio
- LXP $128.85
- AMRX N/A
- Revenue Growth
- LXP 0.56
- AMRX 12.32
- 52 Week Low
- LXP $8.09
- AMRX $5.01
- 52 Week High
- LXP $10.57
- AMRX $9.48
- Technical
- Relative Strength Index (RSI)
- LXP 23.27
- AMRX 39.52
- Support Level
- LXP $9.07
- AMRX $7.59
- Resistance Level
- LXP $9.07
- AMRX $8.18
- Average True Range (ATR)
- LXP 0.21
- AMRX 0.28
- MACD
- LXP -0.10
- AMRX -0.05
- Stochastic Oscillator
- LXP 13.14
- AMRX 15.79
About LXP LXP Industrial Trust (Maryland REIT)
LXP Industrial Trust is a real estate investment trust principally involved in the ownership of equity and debt investments in single-tenant properties and land throughout the United States. Majority of the revenue is earned through rental revenue.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.